Radiotherapy and systemic therapies have revolutionised cancer treatments and improved survival, with generally acceptable toxicity. Modern radiotherapy techniques offer precision in targeting tumours, while minimising harm to the surrounding tissues. Novel systemic therapies represent opportunities for combining innovative treatments with radiotherapy. New agents are increasingly more tumour-specific than chemotherapy, and new rational combinations with radiotherapy are emerging, allowing for a…
[Policy Review] Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapy
The Lancet Oncology | | Antonio Angrisani, Youlia Kirova, Azadeh Abravan, Carlotta Becherini, Sergi Benavente, Luis Castelo-Branco, Anthony J Chalmers, Sebastian M Christ, Eric Deutsch, Andrea Riccardo Filippi, Lizza E L Hendriks, Zita Zolcsók, Tim Illidge, Andreas Rimner, Fernanda Herrera, Dirk De Ruysscher
Topics: blood-cancer, chemotherapy, radiation, research